Perfil
Andrew John Scott Walton-Green is currently the Chairman at Biosceptre (Aust) Pty Ltd. and Biosceptre International Ltd. He is also a Director at Project Better Energy Ltd. In the past, he served as the Chief Executive Officer at Gresham Technologies Plc from 2000 to 2010.
Cargos activos de Andrew Walton-Green
| Empresas | Cargo | Inicio |
|---|---|---|
Biosceptre (Aust) Pty Ltd.
Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops oncology immunotherapies for applications in the diagnosis and treatment of cancer | Presidente | 20/12/2018 |
Biosceptre International Ltd.
Biosceptre International Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops cancer therapeutics and multiple drugs | Presidente | 01/12/2014 |
Project Better Energy Ltd.
Project Better Energy Ltd. Electric UtilitiesUtilities Engages in generating electric power | Director/Miembro de la Junta | 31/03/2014 |
Antiguos cargos conocidos de Andrew Walton-Green.
| Empresas | Cargo | Fin |
|---|---|---|
| GRESHAM TECHNOLOGIES | Presidente | 28/04/2010 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Gresham Technologies Plc
Gresham Technologies Plc Information Technology ServicesTechnology Services Provides data integrity, reconciliation and enterprise data automation solutions for global financial institutions | Technology Services |
Biosceptre (Aust) Pty Ltd.
Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops oncology immunotherapies for applications in the diagnosis and treatment of cancer | Health Technology |
Project Better Energy Ltd.
Project Better Energy Ltd. Electric UtilitiesUtilities Engages in generating electric power | Utilities |
Biosceptre International Ltd.
Biosceptre International Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops cancer therapeutics and multiple drugs | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Walton-Green
















